You are here: Industry Insights > SARS-CoV-2

News List

Taffix® blocks the Delta Variant of SARS-CoV-2 in addition to the Alpha (UK) and Beta (South African) Variant prnewswire
July 20, 2021
Nasus Pharma today announced data from a collaborative in vitro study with the Central Virology Laboratory, Ministry of Health, Public Health Services, Sheba Medical Center, which demonstrated that the gel layer produced by Taffix®
Diversified Medical Healthcare Acquires RapidRona, Expanding into the Home Wellness Market prnewswire
July 15, 2021
Diversified Medical Healthcare (DMH), has acquired RapidRona, making its foray into the home wellness testing market.
One shot of the Sputnik V vaccine triggers strong antibody responses worldpharmanews
July 14, 2021
A single dose of the Sputnik V vaccine may elicit significant antibody responses against SARS-CoV-2, finds a study published July 13 in the journal Cell Reports Medicine.
"Long COVID": More than a quarter of COVID-19 patients still symptomatic after 6 months worldpharmanews
July 14, 2021
In a new study of adults from the general population who were infected with COVID-19 in 2020, more than a quarter report not having fully recovered after six to eight months.
Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus americanpharmaceuticalreview
July 14, 2021
Seegene Inc, a South Korean biotechnology firm, announced the launch of a SARS-CoV-2 variant diagnostic test capable of detecting new virus variants including the Delta and the Delta Plus that have become the dominant virus around the world.
Scientists repurpose cancer and seizure medications to aid in the fight against COVID-19 firstwordpharma
July 14, 2021
The COVID-19 pandemic has caused more than 600,000 deaths in the United States since the start of 2020 and more than 4 million globally.
Study finds nasal COVID-19 vaccine blocks transmission, prevents disease in animals expresspharma
July 13, 2021
The researchers noted that the vaccine only requires a single dose and it may be stored at normal refrigerator temperatures for up to at least three months.
Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant firstwordpharma
July 13, 2021
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) announced today that its COVID-19 mAb cocktail AR-712 binds and neutralizes the Delta variant virus SARS-CoV-2 at a highly effective level (~20ng/mL).
ReiThera Announces Preliminary Phase 2 Data from its COVID-19 Vaccine Candidate prnewswire
July 13, 2021
ReiThera Srl today announces the preliminary safety and immunogenicity data from the Phase 2 clinical "COVITAR" trial with GRAd-COV2, its novel COVID-19 vaccine candidate.
Ortho Clinical Diagnostics' Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization prnasia
July 12, 2021
Ortho Clinical Diagnostics announced its VITROS® Anti-SARS-CoV-2 IgG Quantitative Test is the first quantitative COVID-19 IgG antibody test to receive U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page